Kaposi s Sarcoma (KS) Active Not Recruiting Phase 2 Trials for Valganciclovir (DB01610)

Also known as: Kaposi's sarcomas / Kaposi's sarcoma / Kaposi Sarcoma (KS) / Sarcoma, Kaposi / KaposiĀ“s Sarcoma / Kaposi Sarcoma / Kaposi' s Sarcoma / Multiple idiopathic hemorrhagic sarcoma / Multiple idiopathic haemorrhagic sarcoma / Kaposi's sarcoma, unspecified / Kaposi's sarcoma NOS / Multiple haemorrhagic sarcoma / Multiple hemorrhagic sarcoma

IndicationStatusPhase
DBCOND0035013 (Kaposi s Sarcoma (KS))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03296553Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi SarcomaTreatment